Literature DB >> 5212297

Determining the extent of the cancer and clinical planning for cure.

D A Karnofsky.   

Abstract

The patient with presumed localized cancer should be carefully surveyed both for evidence of spread of the disease, and in order to obtain baseline data which may be relevant to interpret any later clinical changes. The procedures used--a careful medical history, complete physical examination, laboratory tests, biopsy and cytology preparations, radiographic procedures and radioactive isotope scans of selected organ system--are listed. The recommended procedures in the individual patient are related to the primary site and apparent local extent of the cancer, a knowledge of the natural history of the particular cancer, and the practicalities of the situation. Proper study will direct an attempt at optimal curative therapy or spare the patient with metastatic disease unrewarding and possibly disabling therapeutic efforts.

Entities:  

Mesh:

Year:  1968        PMID: 5212297     DOI: 10.1002/1097-0142(196810)22:4<730::aid-cncr2820220407>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Racial disparities in the outcomes of communication on medical care received near death.

Authors:  Jennifer W Mack; M Elizabeth Paulk; Kasisomayajula Viswanath; Holly G Prigerson
Journal:  Arch Intern Med       Date:  2010-09-27

2.  Outcomes of Prognostic Disclosure: Associations With Prognostic Understanding, Distress, and Relationship With Physician Among Patients With Advanced Cancer.

Authors:  Andrea C Enzinger; Baohui Zhang; Deborah Schrag; Holly G Prigerson
Journal:  J Clin Oncol       Date:  2015-10-05       Impact factor: 44.544

3.  End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences.

Authors:  Jennifer W Mack; Jane C Weeks; Alexi A Wright; Susan D Block; Holly G Prigerson
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

4.  Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death.

Authors:  Andrea C Enzinger; Baohui Zhang; Jane C Weeks; Holly G Prigerson
Journal:  J Pain Symptom Manage       Date:  2013-10-05       Impact factor: 3.612

5.  Accuracy of Oncologists' Life-Expectancy Estimates Recalled by Their Advanced Cancer Patients: Correlates and Outcomes.

Authors:  Jason Lambden; Baohui Zhang; Robert Friedlander; Holly G Prigerson
Journal:  J Palliat Med       Date:  2016-08-30       Impact factor: 2.947

6.  Minor cognitive impairments in cancer patients magnify the effect of caregiver preferences on end-of-life care.

Authors:  Xin Gao; Holly G Prigerson; Eli L Diamond; Baohui Zhang; Alexi A Wright; Fremonta Meyer; Paul K Maciejewski
Journal:  J Pain Symptom Manage       Date:  2012-07-28       Impact factor: 3.612

7.  Peace, Equanimity, and Acceptance in the Cancer Experience (PEACE): validation of a scale to assess acceptance and struggle with terminal illness.

Authors:  Jennifer W Mack; Matthew Nilsson; Tracy Balboni; Robert J Friedlander; Susan D Block; Elizabeth Trice; Holly G Prigerson
Journal:  Cancer       Date:  2008-06       Impact factor: 6.860

8.  Measuring therapeutic alliance between oncologists and patients with advanced cancer: the Human Connection Scale.

Authors:  Jennifer W Mack; Susan D Block; Matthew Nilsson; Alexi Wright; Elizabeth Trice; Robert Friedlander; Elizabeth Paulk; Holly G Prigerson
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

9.  The interactive effect of advanced cancer patient and caregiver prognostic understanding on patients' completion of Do Not Resuscitate orders.

Authors:  Megan Johnson Shen; Kelly M Trevino; Holly G Prigerson
Journal:  Psychooncology       Date:  2018-04-30       Impact factor: 3.894

10.  United states acculturation and cancer patients' end-of-life care.

Authors:  Alexi A Wright; Heather Stieglitz; Yankel M Kupersztoch; M Elizabeth Paulk; Yookyung Kim; Ingrid T Katz; Francisco Munoz; Rachel B Jimenez; Jan Mutchler; Lorna Rivera; Anthony L Back; Holly G Prigerson
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.